Bright Minds Biosciences Statistics
Total Valuation
DRUG has a market cap or net worth of $254.45 million. The enterprise value is $250.06 million.
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024, before market open.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DRUG has 6.97 million shares outstanding. The number of shares has increased by 19.17% in one year.
| Current Share Class | 6.97M |
| Shares Outstanding | 6.97M |
| Shares Change (YoY) | +19.17% |
| Shares Change (QoQ) | +4.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 186,278 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 57.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 35.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 35.08 |
| Quick Ratio | 34.75 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -536.85 |
Financial Efficiency
Return on equity (ROE) is -51.80% and return on invested capital (ROIC) is -30.53%.
| Return on Equity (ROE) | -51.80% |
| Return on Assets (ROA) | -28.86% |
| Return on Capital (ROIC) | -30.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2,978.28% in the last 52 weeks. The beta is 1.13, so DRUG's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +2,978.28% |
| 50-Day Moving Average | 23.62 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 51.47 |
| Average Volume (20 Days) | 515,443 |
Short Selling Information
The latest short interest is 322,606, so 4.63% of the outstanding shares have been sold short.
| Short Interest | 322,606 |
| Short Previous Month | 1.17M |
| Short % of Shares Out | 4.63% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.49M |
| Pretax Income | -3.82M |
| Net Income | -2.62M |
| EBITDA | n/a |
| EBIT | -2.49M |
| Earnings Per Share (EPS) | -$0.63 |
Full Income StatementBalance Sheet
The company has $4.52 million in cash and $10,241 in debt, giving a net cash position of $4.51 million or $0.65 per share.
| Cash & Cash Equivalents | 4.52M |
| Total Debt | 10,241 |
| Net Cash | 4.51M |
| Net Cash Per Share | $0.65 |
| Equity (Book Value) | 4.46M |
| Book Value Per Share | 1.00 |
| Working Capital | 4.45M |
Full Balance SheetCash Flow
| Operating Cash Flow | -1.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | -1.84M |
| FCF Per Share | -$0.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |